Related Experiment Video
Updated: Aug 9, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Membrane initiated estrogen signaling in breast cancer
Robert X-D Song1, Richard J Santen
1Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville, Virginia 22903, USA. rs5wf@virginia.edu
Abstract:
Recent research has focused on effects of the estrogen receptor acting at the level of the cell membrane in breast cancer. In this review we describe 17beta-estradiol (E2)-initiated membrane signaling pathways involving the activation of several kinases that contribute to the regulation of cell proliferation and prevention of apoptosis. Although classical concepts had assigned priority to the nuclear actions of estrogen receptor, recent studies document the additional importance of estrogen receptor residing in or near the plasma membrane. A small fraction of estrogen receptor is associated with the cell membrane and mediates the rapid effects of E2. Unlike classical growth factor receptors, such as insulin-like growth factor 1 receptor (IGF1R) and epidermal growth factor receptor (EGFR), estrogen receptor has no transmembrane and kinase domains and is known to initiate E2 rapid signals by forming a protein complex with many signaling molecules. The formation of the protein complex is a critical step, leading to the activation of the MAPK1/3 (also known as MAP kinase) and AKT1 (also known as Akt) pathways. A full understanding of the mechanisms underlying these relationships, with the ultimate aim of abrogating specific steps, should lead to more-targeted strategies for treatment of hormone dependent-breast cancer.
Insights
Estrogen receptor membrane signaling rapidly impacts breast cancer cell proliferation and survival. Understanding these pathways is key to developing targeted cancer therapies.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Classical understanding of estrogen receptor (ER) focused on nuclear actions.
- Emerging research highlights ER's role at the cell membrane in breast cancer.
- Estrogen receptor mediates rapid cellular responses to 17beta-estradiol (E2).
Purpose of the Study:
- To review E2-initiated membrane signaling pathways involving ER.
- To elucidate the role of membrane-associated ER in breast cancer.
- To explore mechanisms for targeted breast cancer treatment strategies.
Main Methods:
- Literature review of recent research on membrane ER signaling.
- Description of E2-initiated signaling cascades.
- Analysis of ER's interaction with signaling molecules.
Main Results:
- Membrane ER activates kinases like MAPK1/3 and AKT1, regulating cell proliferation and apoptosis.
- ER forms protein complexes to initiate rapid E2 signals, distinct from classical growth factor receptors.
- ER lacks transmembrane and kinase domains, relying on complex formation for signaling.
Conclusions:
- Membrane-initiated ER signaling is crucial in hormone-dependent breast cancer.
- Understanding these rapid signaling pathways can inform novel therapeutic strategies.
- Targeting specific steps in membrane ER signaling may improve breast cancer treatment efficacy.
Related Concept Videos
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Mitogens and the Cell Cycle
Internal Receptors
Amplifying Signals via Second Messengers
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

